US GDUFA III Talks In Final Stages, Agreement Nearly Complete

 
• By Derrick Gingery

Final commitment letter preparations now under way as revenue issues are resolved.

Hands reaching out to each other.
Industry and FDA representatives agreed that any remaining GDUFA III sessions will be scheduled as needed. • Source: Alamy

More from Generics

More from Biosimilars & Generics